<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04586361</url>
  </required_header>
  <id_info>
    <org_study_id>200527-2</org_study_id>
    <nct_id>NCT04586361</nct_id>
  </id_info>
  <brief_title>Prospective Analysis of Introperative RegenLab PRP and Hyaluronic Acid in Patients With Knee ACL Tear</brief_title>
  <official_title>Prospective Analysis of Introperative RegenLab PRP and Hyaluronic Acid in Patients With Knee ACL Tear</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kaohsiung Veterans General Hospital.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kaohsiung Veterans General Hospital.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Purpose: The purpose of this article is to examine the clinical application of PRP and&#xD;
      PRP+hyaluronic acid in disorders in the knee.&#xD;
&#xD;
      Methods:&#xD;
&#xD;
      The study was conducted on 150 adult patients with age over 20 years old affected by&#xD;
      unilateral ACL complete tear and receiving ACL reconstruction. We divided the patients in&#xD;
      three groups, and we treated the group A with perioperative injection of HHA, group B with&#xD;
      perioperative HHA+PRP, group C with perioperative normal saline.&#xD;
&#xD;
      Follow-up:&#xD;
&#xD;
      Every 1,3,and 12months, we recheck physical exmianation at OPD and recheck MRI at&#xD;
      postoperative 3 months.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">October 15, 2020</start_date>
  <completion_date type="Anticipated">September 15, 2022</completion_date>
  <primary_completion_date type="Anticipated">September 15, 2021</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>150 of participants with preoperative and postoperative physical examination are accessed by anterior drawer test and Lachman test</measure>
    <time_frame>postoperative 1 month</time_frame>
    <description>the investigators recheck physical exmianation of participants at OPD; physical examination was checked by one orthopedist</description>
  </primary_outcome>
  <primary_outcome>
    <measure>150 of participants with preoperative and postoperative physical examination are accessed by anterior drawer test and Lachman test</measure>
    <time_frame>postoperative 3 months</time_frame>
    <description>the investigators recheck physical exmianation of participants at OPD; physical examination was checked by one orthopedist</description>
  </primary_outcome>
  <primary_outcome>
    <measure>150 of participants with preoperative and postoperative physical examination are accessed by anterior drawer test and Lachman test</measure>
    <time_frame>postoperative 12 months</time_frame>
    <description>the investigators recheck physical exmianation of participants at OPD; physical examination was checked by one orthopedist</description>
  </primary_outcome>
  <primary_outcome>
    <measure>150 of participants with preoperative and postoperative Magnetic Resonance Imaging are accessed</measure>
    <time_frame>postoperative 3 month</time_frame>
    <description>anterior cruciate ligament was accessed by MRI T1 and T2 image; MRI was checked by one orthopedist</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>PRP</condition>
  <condition>ACL</condition>
  <condition>Hyaluronic Acid</condition>
  <arm_group>
    <arm_group_label>Experimental group 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intraoperative1 kit of Platelet-rich plasma(PRP) injection into knee joint after anterior cruciate ligament (ACL) reconstruction.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Experimental group 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intraoperative1 kit of PRP+Hyaluronic acid(HA) injection into knee joint after ACL reconstruction.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Experimental group 3</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Intraoperative 20 ml normal saline injection into knee joint after ACL reconstruction.</description>
  </arm_group>
  <intervention>
    <intervention_type>Combination Product</intervention_type>
    <intervention_name>RegenLab PRP</intervention_name>
    <description>PRP preparations also improved functional outcome scores compared to hyaluronic acid and placebo in patients affected by knee osteoarthritis (OA). Based on previous studys, we can conclude that the PRP treatment is a safe and efficacious procedure which can provide functional benefit.</description>
    <arm_group_label>Experimental group 1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Combination Product</intervention_type>
    <intervention_name>hyaluronic acid</intervention_name>
    <description>Few studies investigated the effects of HA+PRP combined treatment for knee osteoarthritis (OA). Numerous studies demonstrated the efficacy of HA injection therapy in knee OA for a clinical point of view, reducing the pain and improving the quality of life.</description>
    <arm_group_label>Experimental group 2</arm_group_label>
    <other_name>RegenLab PRP</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>normal saline</intervention_name>
    <description>In this study, we compare introperative PRP/PRP+HA/normal saline in ACL reconstruction patient.</description>
    <arm_group_label>Experimental group 3</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  receiving unilateral ACL reconstruction in our hospital&#xD;
&#xD;
          -  postoperative follow-up over 3 month&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  postoperative follow-up less than 3 month&#xD;
&#xD;
          -  possible pregnency&#xD;
&#xD;
          -  with coagulation disease&#xD;
&#xD;
          -  NSAIDs intake during study period&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yi Ping Wei, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kaohsiung Veterans General Hospital.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yi Ping Wei, MD</last_name>
    <phone>+886-7-342-2121</phone>
    <email>xgoznas22@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Kaohsiung Veterans General Hospital</name>
      <address>
        <city>Kaohsiung</city>
        <state>高雄市</state>
        <zip>813</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yi Ping Wei, MD</last_name>
      <phone>073422121</phone>
      <email>xgoznas22@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>September 13, 2020</study_first_submitted>
  <study_first_submitted_qc>October 7, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 14, 2020</study_first_posted>
  <last_update_submitted>October 7, 2020</last_update_submitted>
  <last_update_submitted_qc>October 7, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 14, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kaohsiung Veterans General Hospital.</investigator_affiliation>
    <investigator_full_name>Yi Ping Wei</investigator_full_name>
    <investigator_title>Chief resident, Orthopedics department, Kaohsiung Veterans General Hospital; Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>PRP; ACL reconstruction</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anterior Cruciate Ligament Injuries</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyaluronic Acid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

